11 min read
The GLP-1 Off-Ramp: Opportunity for Supplement Founders
When consumers stop GLP-1 drugs like Ozempic, rapid weight regain creates a supplement opening. Here's how brand founders can position for the GLP-1 off-ramp.
Formulation science, ingredient selection, and dosing guidance for supplement brands. How to pick actives that clear regulatory review, choose formats that match your consumer, and balance cost, efficacy, and stability without over-engineering a new SKU.
When consumers stop GLP-1 drugs like Ozempic, rapid weight regain creates a supplement opening. Here's how brand founders can position for the GLP-1 off-ramp.
Creatine is being reclassified as a conditionally essential nutrient. Here is what the proposed 2026 DRI framework means for supplement brand founders today.
LumaNutra helps health product brands move from concept to retail. Formulation, manufacturing, regulatory, and brand strategy under one roof.